MedicalgorithmicsFRA:B8E -3.10%72 Days Payable is 405.61 as of Mar. 2026, which is 165% above its 10-year median of 152.91. GuruFocus rates FRA:B8E with a GF Score™ of 72/100 and a GF Value™ of €6.00. The stock has 4 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Medicalgorithmics ranks better than 91.32% on this metric.
The historical rank and industry rank for Medicalgorithmics's Days Payable or its related term are showing as below:
FRA:B8E'
s Days Payable Range Over the Past 10 Years
Min: 73.38 Med: 152.91 Max: 3014.43
Current: 406.68
During the past 13 years, Medicalgorithmics's highest Days Payable was 3014.43. The lowest was 73.38. And the median was 152.91.
FRA:B8E's Days Payable is ranked better than 91.32% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs FRA:B8E: 406.68
Medicalgorithmics's Days Payable
increased
from Mar. 2025 (181.70) to Mar. 2026 (405.61).
It may suggest that Medicalgorithmicsdelayed paying its suppliers.
Medicalgorithmics Days Payable Related Terms
Medicalgorithmics Days Payable Historical Data
* Premium members only.
The historical data trend for Medicalgorithmics's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Medicalgorithmics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medicalgorithmics Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medicalgorithmics's Days Payable distribution charts can be found below:
* The bar in red indicates where Medicalgorithmics's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Medicalgorithmics's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medicalgorithmics (FRA:B8E) has a Days Payable of 405.61 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medicalgorithmics and its competitors. This is 165% above median its historical median of 152.91. Over the past decade, Medicalgorithmics' Days Payable has ranged from 73.38 to 3,014.43. According to the industry distribution chart, Medicalgorithmics ranks #69 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 8.7%.
Is Medicalgorithmics' Days Payable too high?
Medicalgorithmics' current Days Payable of 405.61 is 165% above median its 10-year median of 152.91. Over the past 10 years, this metric has ranged from a low of 73.38 to a high of 3,014.43. The Medical Devices & Instruments industry median Days Payable is 68.07. Medicalgorithmics' value of 405.61 is 495.9% above this industry median. Based on the distribution chart, Medicalgorithmics ranks #69 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Medicalgorithmics has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Medicalgorithmics' Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medicalgorithmics ranks #69 out of 795 companies for Days Payable. This places Medicalgorithmics in the top 9% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.07. Medicalgorithmics' value of 405.61 is 495.9% above this benchmark. Historically, Medicalgorithmics' own Days Payable has ranged from 73.38 to 3,014.43 over the past decade. While the company's 10-year median is 152.91 vs. the industry median of 68.07, Medicalgorithmics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medicalgorithmics's current Days Payable of 405.61 is 495.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medicalgorithmics and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicalgorithmics's current Days Payable is 405.61, which is 165% above median its own 10-year median of 152.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicalgorithmics stock overvalued right now?
Medicalgorithmics (FRA:B8E) has a current Days Payable of 405.61. The stock's GF Value™ is €6.00, compared to a current price of €5.94 — trading 1% below its estimated fair value. The current Days Payable is 405.61, which is 165% above median its 10-year median of 152.91 and 495.9% above the Medical Devices & Instruments industry median of 68.07. Medicalgorithmics' overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Medicalgorithmics (FRA:B8E), the current Days Payable is 405.61 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medicalgorithmics (FRA:B8E) Overvalued in 2026?
Based on GuruFocus' analysis, Medicalgorithmics stock appears to be undervalued.
The current stock price of €5.94 is trading 1% below its estimated GF Value™ of €6.00.
Key valuation signals for FRA:B8E:
Days Payable: 405.61 (165% above median its 10-year median of 152.91)
GF Value™: €6.00 vs. price of €5.94 (1% below fair value)
Industry Position: 495.9% above the Medical Devices & Instruments median (#69 of 795)
No single metric tells the full story. See the FRA:B8E stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medicalgorithmics SA is a medical technology company. It is engaged in the development of Digital Signal Processing (DSP) algorithms development and software and hardware electronics design for medical applications. The company specializes in providing advance technological solutions in the field of cardiac diagnostics, with a particular focus on ECG signal analysis. The group concentrates on the production and development of its flagship product Pocket ECG - a system for remote monitoring of cardiac arrhythmias. The offered solutions include algorithms and diagnostic systems used in remote heart monitoring. The company operates in Poland, the USA, and other, with majority of revenue from the USA.
72GF Score
Get the complete analysis for FRA:B8E
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:B8E has been successfully added to your 
